BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/5/2022 2:53:48 AM | Browse: 370 | Download: 658
 |
Received |
|
2021-06-02 19:27 |
|
Peer-Review Started |
|
2021-06-02 19:30 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-07-31 03:58 |
|
Revised |
|
2021-08-04 15:47 |
|
Second Decision |
|
2021-12-13 03:30 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-12-23 05:46 |
|
Articles in Press |
|
2021-12-23 05:46 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-31 08:38 |
|
Publish the Manuscript Online |
|
2022-01-05 02:53 |
| ISSN |
2220-3141(online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Noncommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Vijairam Selvaraj, Amos Lal, Arkadiy Finn, Joshua Ray Tanzer, Muhammad Baig, Atin Jindal, Kwame Dapaah-Afriyie and George Bayliss |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Amos Lal, FACP, MBBS, Assistant Professor, Medicine, Division of Pulmonary and Critical Care, Mayo Clinic, 200 1st St SW, Rochester, Minnesota 55905, United States. manavamos@gmail.com |
| Key Words |
COVID-19; Remdesivir; End stage renal disease; Dialysis; Hemodialysis; Kidney disease |
| Core Tip |
Little known information exists regarding the efficacy of remdesivir in corona virus disease 2019 patients with end stage renal disease on dialysis. Use of remdesivir was associated with a trend towards reduced oxygen requirement, reduced probability of progression to mechanical ventilation and better prognosis. Larger studies are justified in this high risk, vulnerable population. |
| Publish Date |
2022-01-05 02:53 |
| Citation |
Selvaraj V, Lal A, Finn A, Tanzer JR, Baig M, Jindal A, Dapaah-Afriyie K, Bayliss G. Efficacy of remdesivir for hospitalized COVID-19 patients with end stage renal disease. World J Crit Care Med 2022; 11(1): 48-57 |
| URL |
https://www.wjgnet.com/2220-3141/full/v11/i1/48.htm |
| DOI |
https://dx.doi.org/10.5492/wjccm.v11.i1.48 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
